Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled studyGregory M Asnis
Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th St, Bronx, NY 10467
J Clin Psychiatry 74:242-8. 2013
....
Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatientsG M Asnis
Department of Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center, 111 E 210th Street, Bronx, New York, NY 10467 2490, USA
Psychiatry Res 103:1-14. 2001
..Significant improvement was evident as early as week 1 for some panic variables. Fluvoxamine is a potent anti-panic agent with a relatively rapid onset of action...
- Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches
Gregory M Asnis
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, Anxiety and Depression Program, Klau Basement, 111 E 210th Street, Bronx, New York 10467, USA
J Clin Gastroenterol 40:322-35. 2006
..Finally, a discussion is provided on the use of antidepressants as a preventative versus restorative treatment, including a commentary on risks of using antidepressants in this patient population...
- IFN-induced depression: a role for NSAIDs
Gregory M Asnis
Department of Internal Medicine, Yeshiva University s Albert Einstein College of Medicine, and Anxiety and Depression Program, Montifiore Medical Center, Bronx, NY, USA
Psychopharmacol Bull 37:29-50. 2003
....
- Interferon-induced depression: strategies in treatment
Gregory M Asnis
Albert Einstein College of Medicine, Montefiore Medical Center, Anxiety and Depression Program, 111 E 210th Street, Bronx, NY, USA
Prog Neuropsychopharmacol Biol Psychiatry 29:808-18. 2005
..On the basis of known and effective treatment strategies, IFN-induced depression should not be an obstacle for continued treatment in most patient populations...
- SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations
Gregory M Asnis
Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA
Drugs 64:383-404. 2004
....
- Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C
C L Raison
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
Aliment Pharmacol Ther 25:1163-74. 2007
..Whether antidepressants prevent depression during interferon-alpha/ribavirin treatment for hepatitis C virus infection has yet to be established...
- Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial
K Brady
Department of Psychiatry, Medical University of South Carolina, Charleston 29425, USA
JAMA 283:1837-44. 2000
..Despite the high prevalence, chronicity, and associated comorbidity of posttraumatic stress disorder (PTSD) in the community, few placebo-controlled studies have evaluated the efficacy of pharmacotherapy for this disorder...
- Ribavirin may be an important factor in IFN-induced neuropsychiatric effects
Gregory M Asnis
J Clin Psychiatry 65:581; author reply 581-2. 2004
- Combined antidepressant treatment: a risk factor for switching in bipolar patients
Vilma Gabbay
J Clin Psychiatry 63:367; author reply 367-8. 2002
- Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats
Richard De La Garza
Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, 740 Westwood Boulevard, NPI A8 148, Los Angeles, CA 90024, USA
Prog Neuropsychopharmacol Biol Psychiatry 29:781-92. 2005
..Despite the neurochemical alterations observed in the chronic treatment regimen, the data indicate that recombinant human IFN-alpha does not produce a robust model of depressive-like behavior in rodents...
- Interferon for hepatitis C patients with psychiatric disorders
Gregory M Asnis
Am J Psychiatry 161:2332; author reply 2332-4. 2004
- Neuropsychiatric impact of hepatitis C on advanced HIV
Gregory M Asnis
Neurology 64:768; author reply 768. 2005
- The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release
Richard De La Garza
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Forchheimer Building, Room 111, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Behav Brain Res 149:77-85. 2004
....
- Safety and tolerability of lamotrigine for bipolar disorder
Charles L Bowden
Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 3900, USA
Drug Saf 27:173-84. 2004
..These findings - considered in the context of data showing lamotrigine to be effective for bipolar depression - establish lamotrigine as a well-tolerated addition to the psychotropic armamentarium...
- Increased personality disorders and Axis I comorbidity in atypical depression
Lata K McGinn
Ferkauf Graduate School of Psychology, Yeshiva University, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Compr Psychiatry 46:428-32. 2005
..Comparison of patients with and without atypical depression on comorbid Axis I and I disorders to determine whether atypical depression is associated with a higher comorbidity...
- The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus
Richard De La Garza
Albert Einstein College of Medicine, Department of Psychiatry and Behavioral Sciences, Forchheimer, Room 111, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Brain Res 977:70-9. 2003
..These data offer support for a novel role of NSAIDs in modulating IFN-alpha-induced neurochemical alterations, and raise the possibility of the use of NSAIDs for the prevention of IFN-alpha-induced depression...
- Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management
Michael J Maher
Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA
CNS Drugs 20:567-90. 2006
..Controlled studies are needed to confirm these promising findings...
- Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder
Arifulla Khan
Northwest Clinical Research Center, Bellevue, Wash 98004, USA
J Clin Psychiatry 65:1483-90. 2004
..This analysis describes the effects of bipolar I disorder on self-reported neurocognitive measures and remediation of these deficits with lamotrigine therapy...
- Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats
Richard De La Garza
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Forchheimer Building, Room 111, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Psychopharmacology (Berl) 179:356-65. 2005
....
